Stephany Verstraete - 03 Nov 2021 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Role: Chief Marketing Officer
Signature: /s/ Adam C. Vandervoort, attorney-in-fact
Issuer symbol: TDOC
Transactions as of: 03 Nov 2021
Net transactions value: -$115,700
Form type: 4
Filing time: 04 Nov 2021, 16:11:29 UTC
Next filing: 02 Mar 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TDOC	Common Stock	Options Exercise	$38,550	+1,000	+4.5%	$38.55	23,278	03 Nov 2021	Direct	F1
transaction	TDOC	Common Stock	Sale	$154,250	-1,000	-4.3%	$154.25^*	22,278	03 Nov 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TDOC	Employee Stock Option (right to buy)	Options Exercise	$0	-1,000	-2.2%	$0.000000	45,331	03 Nov 2021	Common Stock	1,000	$38.55	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on August 16, 2021.
F2	The option vested as to 25% of the shares on March 1, 2019. The remainder of the shares vest in 36 substantially equal monthly installments thereafter.